Mometasone furoate didn’t just appear out of nowhere. Its story is rooted in decades of corticosteroid research. Scientists spent years looking for a compound that would fight inflammation without turning people’s lives upside down. In the late 1980s, researchers fine-tuned mometasone by adding a furoate ester. This wasn’t just a trivial tweak. The addition helped the molecule punch above its weight in the body’s inflammatory cycle but kept systemic effects to a minimum. A key feature: it stays where it’s needed, especially when used in skin or nasal applications, which lowers the risk of side effects like suppressed adrenal function. Mometasone drew a lot from the lessons learned with earlier steroids like hydrocortisone and betamethasone—but it forged its own practical path in pharmacological history.
Spend some time at a community pharmacy, and you’ll see mometasone furoate products in various forms: nasal sprays for allergies, creams for skin rashes, inhalers for asthma. The stuff at the heart of these products works the same way—blocking the messengers that trigger redness, itch, and swelling. Each formulation goes through strict quality checks, partly so people can trust the package matches the promise. Lay it out plain: folks with eczema want relief with less worry about skin thinning, and allergy sufferers want to breathe easier without feeling jittery or foggy. Mometasone furoate took hold because it delivers on these needs for millions every year.
Mometasone furoate catches the eye in the lab—white to faintly yellow powder, no real scent, and doesn’t dissolve in water worth mentioning. The chemical structure looks a lot like other glucocorticoids: steroid nucleus, with a furoate group hanging off. This addition doesn’t just sit there; it creates a sharp divide between the compound’s oil-loving and water-loving qualities. That split underpins its ability to linger where applied, making topical doses more effective. People talk about melting points and solubility—mometasone clocks in with a melting point around 220–230°C, practically heatproof for daily use. The molecule almost shrugs off common solvents—ethanol and methanol work, but not much else. Stability under regular lighting and room temperature rounds out the profile, so it doesn’t lose clout during transport or storage.
Regulations force every manufacturer to stamp the package with clear, honest information. The U.S. FDA and EMA both spell out what must appear: drug strength (from 0.1% for creams to precisely dosed micrograms per spray for nasals), usage instructions, lot numbers, and expiration dates. Good labeling goes far beyond legalese. It arms patients and doctors with the right dosing, warns about overuse, and calls out allergies. It’s not abstract paperwork—mistakes here lead to improper use, so companies lay it all out, from warnings about kids to possible drug interactions. The technical language behind the scenes keeps the supply chain straight and the patient safe.
The process for synthesizing mometasone furoate gets complicated fast. Starting from hydrocortisone-like base structures, chemists weave in fluorine atoms and protect certain alcohol groups. They rely on selective catalysts and temperature control. The standout step: introducing the furoate moiety. This reaction requires careful timing and control to avoid making byproducts. After synthesis, purification pulls out unreacted ingredients and chemical siblings, leaving behind only the potent main compound. Every batch goes through repeat testing—chromatography for purity and potency checks so the medication lives up to its label.
In the lab, mometasone furoate holds up well. It resists breaking down from mild acids and bases, thanks to its structure. Scientists sometimes tinker with the furoate group or shift the chlorine and fluorine around the ring to play with how the drug works in the body. These modifications can push half-life, absorbency, or local effect in a new direction. Formulation teams play with its solubility to tweak sprays, creams, and inhalers for rapid or steady release. The field keeps testing subtle changes, always on the lookout for the next big jump in precision or safety.
Look at boxes in the drugstore and see more than one name for this compound. Chemists refer to it as the furoate ester of mometasone. Pharmacists and patients check names like Nasonex, Elocon, or Asmanex, depending on the form of delivery. Others simply call it mometasone, leaving off the “furoate” for simplicity. Each name signals a different purpose, but underneath, the molecule remains the same. The variety of brands creates options but sometimes sows confusion, especially when generics enter the picture. Familiarity with both generic and trade names keeps everyone on the same page.
Doctors think about safety every day because it weighs directly on the trust people place in their advice. Mometasone furoate scores points by targeting the problem area, which slashes the odds of whole-body side effects like Cushing’s syndrome or bone weakness. The main issues tie into overuse—long stretches, especially under wraps or over large skin surface areas, can invite thinning or bruising. For nasal sprays, occasional nosebleeds or headaches make the list, but these tend to fade with steady, proper use. Operational standards call for clean facilities and rigorous tracking during manufacturing, right down to the cleaning logs between production lots. The stakes are high; a single contaminated batch can spell disaster for both health and reputation. Clinical teams keep an eye on side effects by sifting through safety reports and updating guidelines as patterns emerge.
Mometasone furoate stretches across medicine: The thick of allergy season, children playing outside in dusty parks, parents looking for relief from eczema that won’t ruin a child’s sleep. Nasal sprays hit hard against rhinitis—sneezing, itchy noses, stubborn congestion. Skin creams shine in taming rashes, psoriasis, and stubborn patches of eczema. Asthma patients benefit from inhalers loaded with mometasone, breathing easier without a pile of oral steroids. The applications come back to a single thread: wanting relief without trading off quality of life. Hospitals and clinics keep mometasone products as staples, knowing the relief they bring can get kids back to school and adults back to work.
Pharmaceutical researchers spend their careers tweaking molecules and studying lives impacted by persistent inflammation. Mometasone furoate attracts attention not for being the newest kid on the block, but for filling tough jobs reliably. R&D teams keep hunting for even more targeted versions: micro-encapsulated creams for slow, steady delivery, or ultra-fine nasal mists that coat the lining evenly. Clinical trials test how mometasone interacts with the growing list of biologic immune therapies on the market. Formulation teams strive for patches that stay put during sweaty exercise or inhalers that resist humidity in tropical climates. They all share a goal: shorten flare-ups, lower risk, and keep cost within reach for patients who can’t wait out the next round of symptoms.
Scientists take no shortcuts in measuring toxicity. For mometasone furoate, early animal studies watched for changes in growth, bone density, and hormone levels with long-term exposure. Toxicologists mapped side effects carefully, painting a full picture before the first prescription landed in a pharmacy. Ongoing studies track rare but serious reactions, checking whether genetics or combinations with other drugs raise risks. The real-world proof comes from post-marketing surveillance—tens of millions of doses, with pharmacists, doctors, and patients reporting events to safety databases. This mountain of data helps weed out hidden dangers and build detailed warning labels, allowing for smart choices at every stage.
A look forward at mometasone furoate’s role shows there’s never a finish line in drug development. Even as the landscape fills with newer biologic drugs aimed at allergic and autoimmune diseases, mometasone tools hold their ground—cost, access, and established safety records matter. Old molecules still find new homes; research is pushing for nano-carriers that could let a pinpoint dose slip deeper into the skin or lung. Personalized medicine is coming up fast, so teams study genetic profiles to find out who gains the biggest relief and faces the smallest risks with mometasone products. As climate and urban pollution raise allergy and asthma rates, the world needs more, not fewer, safe options for every age and background. The next decades will see both trusted forms and surprising new applications, keeping this humble molecule in bathrooms and hospitals alike.
Many folks know that itching and sneezing make daily life a pain. I’ve watched friends and family deal with eczema and allergies, seeing them tug at their sleeves to cover red, irritated skin. Pollen days roll in, and some folks can’t stop rubbing their noses or eyes. Doctors keep hearing the same complaints. Mometasone furoate helps address those difficulties. This medicine stands out in many medicine cabinets for good reason.
This steroid cream, spray, or inhaler doesn’t just target one tiny problem; it goes for the root of allergic inflammation. In the world of skin issues, people reach for mometasone furoate to tame flare-ups of atopic dermatitis, psoriasis, and contact dermatitis. Expect swelling and itching to go down not long after using it according to a doctor’s advice. It calms angry skin more thoroughly than most over-the-counter lotions can manage.
People living with allergic rhinitis – that’s a stuffy nose and sneezing that never seem to quit – also turn to mometasone furoate, but as a nasal spray. It controls both the snot and the raw, sore tissue inside the nose that comes with allergies. Nasal steroids like this get recommended often because they directly reduce swelling. Sneezing, itching, and congestion back off so people breathe easier, sometimes for the first time in weeks.
Children and adults with asthma sometimes rely on mometasone furoate inhalers. Asthma brings a whole different layer of worry, especially for parents watching over their kids in spring. This medicine helps keep airways from swelling and filling up with mucus. I remember being in the ER as a child and the frantic feeling of not catching my breath. Treatments improved a lot over the years. With medicines like this, people now avoid trips to the emergency room and lead fuller, active lives.
Steroids, especially topical ones, demand careful use. Doctors often say, “Use the smallest amount that controls your symptoms.” They want to prevent thinning skin or nosebleeds. With inhalers, the advice always includes rinsing out the mouth to prevent infections like thrush. Some parents worry about using steroids on their kids, but studies show that, at the right doses, growth gets checked on and safety holds up. The medicine works well because it acts inside the spot needing help instead of flooding the whole body.
The main thing I’ve learned: communication with health professionals leads to the best outcome. If you don’t spot any improvement, talk to your doctor for a new plan. Pharmacists can answer questions and help watch for medicine mix-ups. Prescription insurance covers mometasone furoate in many forms, so check to see what’s on your plan. If costs pile up, ask about generic versions, which often cost less. Proper storage matters too, especially in summer—heat can break down the medicine faster.
Research doesn’t stand still. Scientists keep testing safer steroid medicines and easier-to-use forms so people can live more comfortably, even with allergies, rashes, and lung trouble.
Mometasone furoate sits in the cupboards of many homes. Doctors prescribe it for allergies, asthma, and skin issues from eczema to psoriasis. This medicine delivers reliable results for a lot of people. Still, side effects sometimes sour the experience, making it important to know what to watch for.
Those using mometasone as a cream, ointment, or lotion often look for fast relief from itching and redness. In real life, the first sign of trouble tends to be local: burning, stinging, or dryness where the cream went on. I remember patchy redness on my arm lingering far too long after a brief round of treatment. Some people see tiny bumps called folliculitis or the skin starts to thin and bruise with regular use, especially on thinner areas like the inner elbows or behind the knees. Stretch marks and changes in skin color sometimes crop up as well. These reactions might seem like minor trade-offs, but for young kids or folks with sensitive skin, they can trigger more discomfort than the original rash.
Nasal sprays reroute the medicine straight to the sinuses. This brings quick relief for stuffy noses plagued by allergies, but it also means nosebleeds and irritation pop up more often than the package insert might suggest. I used the spray for spring allergies and found the back of my throat sore and dry within a week. Some users get headaches or sneezing fits. Doctors warn about rare but serious effects like a fungal infection called thrush, mostly in those using high doses or over several months. Parents hear about slowed growth in kids who depend on inhaled steroids. Growth catches up once the medicine stops, but nobody likes to take that risk lightly.
Side effects don’t always stop at mild annoyance. Steroid medicines, even at low doses used in the nose or on the skin, can nudge eye pressure higher. That sets up patients for glaucoma or cataracts over time, underscored by large studies in elderly populations. If skin lets infection through, the body’s immune response takes a hit, too. Suddenly, regular users find themselves fighting off bacterial or fungal infections that struggle to heal.
Steroids affect the body’s hormone balance, and mometasone is no exception. With long-term use or applying large amounts over big skin areas, the adrenal glands slow down hormone production. People might feel tired, dizzy, or weak, especially if they stop the steroid cold turkey. These side effects don’t show up overnight, but slow sneaks add up, especially in children or teens still developing.
Doctors keep a close eye on patients, especially kids who use these products for long periods. Sticking to the lowest effective dose makes a real difference. Rinsing the mouth after sprays or inhalers can knock down thrush risk. Rotating skin application sites gives irritated areas a break. Pharmacists encourage tracking doses, catching problems early, and letting patients know they can bring up concerns anytime.
Research keeps shaping best practices, and new safety tips pop up as more people use these medicines. The key lesson: listen to the body. If new rashes, infections, or vision changes show up, reach out to your provider. For most, mometasone furoate brings more relief than trouble, but careful, informed use improves results for everyone.
Mometasone furoate stands out as a treatment option for all sorts of itchy, rashy, and irritated skin, from stubborn eczema patches to persistent allergic reactions. It works by calming the immune system right down at the skin’s surface, putting the brakes on swelling and redness, and letting the skin recover. Doctors have counted on this corticosteroid cream for decades, but there’s an art to getting the most out of it. Following some basic steps can mean the difference between steady improvement and a cycle of flare-ups.
Here’s how I learned to get it right, after wrestling with eczema through dozens of sticky summers. First, wash your hands and gently clean the skin where you’ll put the cream. A quick lukewarm rinse is all it takes—no scrubbing, no harsh soaps. Pat dry because trapping moisture under a steroid cream can annoy already cranky skin. Squeeze out just a pea-sized amount—too much and you’ll clog pores, too little and you shortchange yourself. Spread the cream in a very light, thin layer. There’s no need to slather it; a film, almost transparent, covers the spot.
Most doctors suggest once daily application for adults, maybe twice if a pediatrician gives the green light for kids. This goes along with what the FDA has approved, and sticking to that plan reduces the odds of side effects like thinning skin or stretch marks. Covering the area with plastic or airtight bandages amps up the potency, but that belongs to special cases under a doctor’s care—self-experimenting brings more risk than reward.
Not all skin spots behave the same. Thinner skin, like eyelids, absorbs the medicine faster. Use even less there and only if your doctor suggests it. Around the mouth, nose, or groin, extra caution pays off, since these areas are quick to betray you with side effects such as discoloration or tiny red bumps. On tough elbows or knees, a bit more cream makes sense, but still keep it thin.
Mometasone furoate clears up rashes for lots of folks in just a week or two. If your skin doesn’t show a change or gets worse in that time, it’s time for a check-in with your healthcare provider. Don’t keep applying past the prescribed time just because you see old flakes or redness—long-term steroid use brings its own set of headaches, including infections and stunted healing.
Mometasone furoate isn’t just another cream—it plays a real part in restoring a sense of control over irritating skin conditions. Poor application wastes the medicine, leaves families frustrated, and can even hurt. I’ve seen parents use multiple tubes in a panic, convinced “more is better,” only to end up at the doctor’s office with raw, painful skin on their kids. Education makes a world of difference. If people understood that careful, measured application does more than a heavy hand, there’d be fewer trips to the pharmacy and happier skin.
Looking up proper use with every new prescription helps. Trusted resources—Mayo Clinic, the American Academy of Dermatology, even most pharmacy websites—spell out steps in language that doesn’t confuse. Pharmacists and doctors expect questions. They don’t mind running through the do’s and don’ts again. With these basics, anyone with a tube of mometasone furoate can make informed choices, avoid side effects, and get relief where it’s needed most.
Parents walk into doctor’s offices every day with children battling eczema, allergies, or stubborn rashes. A familiar name often pops up on prescriptions: mometasone furoate. It comes as a cream, an ointment, a nasal spray, and even as an inhaler for asthma. Kids scratch, skin breaks, discomfort follows, and everyone wants relief. Mometasone promises that. People want to know, though, if using it on their child really won’t do more harm than good.
Doctors rely on research and guidelines. Mometasone furoate shows its benefits in controlled doses. The FDA approves it for kids over two years old, at least for skin use. Dermatologists like it, since studies show less skin-thinning than older steroids. Its anti-inflammatory punch knocks down itch and redness quickly. The nasal spray clears stuffy noses and the inhaler widens tight airways, giving thousands of kids better nights and brighter days.
Steroids, even mild ones, carry risks. I’ve talked to parents more than once who fear steroids might thin their child’s skin, stunt growth, or get into the bloodstream. Studies back up those worries, but they rarely happen with short-term, proper use. Problems start appearing with months of daily use, or careless application to sensitive spots like the face or under tight diapers. Kids absorb more medicine than adults through their skin, especially babies or toddlers. This isn’t just a scientific fact; I’ve seen kids with stretch marks from years of well-meaning steroid use.
Doctors aim for the lowest effective dose, just enough to settle the rash or ease the allergy. For most families, that means using mometasone furoate cream on small patches, once a day, stopping when things clear up. Any medication, even one that comes in a little white tube, deserves respect.
Steroid phobia sometimes leads parents to skip treatment, which lets a child’s sleep, school, and happiness suffer. But throwing caution out the window and coating big areas for weeks opens the door to side effects. There’s a sweet spot — use enough, not too much, not for too long.
Successful use depends on education. Doctors and pharmacists should walk parents through every step: thin layers, short courses, watch for improvement. No silencing of concerns, either. Answering questions about long-term use, or risks to hormones, builds trust. Parents grow more confident when they know what to look for: thinning skin, hair growth, or odd bruising means it’s time for a check-in.
Regular follow-ups allow doctors to keep an eye on the child, to spot trouble early or give the all-clear. Families dealing with eczema do best when they see a plan on paper — triggers, moisturizers, flare instructions, and a clearly labeled steroid. Mometasone furoate only tells part of the story. Consistent skin care, gentle soaps, avoiding scratchy clothes, and stress control all matter just as much.
Families dive into oceans of “natural” eczema cures that don’t always deliver. Mometasone furoate still helps thousands, beaten up by itching or inflamed skin, find peace at bedtime. Under watchful eyes, medium-strength steroid creams allow most kids to run, sleep, and hug freely again. Parent knowledge, clear doctor guidance, and short courses build safety. It’s about balance, learning when to use what’s proven, and moving with care every step of the way.
Mometasone furoate sits in the group of topical steroids. It’s prescribed for skin problems tied to inflammation like eczema, psoriasis, and allergic skin reactions. Doctors know it as a potent medication that calms angry, irritated skin and knocks down redness and itching. But anyone who reads the fine print will notice a warning about facial skin. The face’s skin stays thinner, more sensitive, and less able to handle strong medicines. In my own work as a healthcare writer, I’ve watched people bounce between advice found online and what their doctor lays out. There’s a reason most won’t casually brush mometasone furoate on their cheeks or forehead.
Problems start with overuse. Topical steroids, especially stronger ones like mometasone furoate, can thin out the skin. On the face, this risk gets real—quickly. Think about the fragile skin around the eyes or across the eyelids. After a couple of weeks, some folks spot stretch marks, tiny visible blood vessels, or inexplicably thin patches where the medicine’s been spread. Science draws the line: a study in the British Journal of Dermatology pointed out how strong steroids, even when used for short bursts, open the door to long-term damage on facial skin.
People sometimes come into pharmacies waving their tube of steroid ointment, desperate for relief from a rash. Most adults just want what works. But it’s easy to get stuck in a cycle: apply, see improvement, keep applying, and not notice creeping side effects until it’s too late. Dermatologists often share stories of patients who leaned on strong creams to treat acne, rosacea, or dermatitis—only to end up with bigger problems. Steroid-induced rosacea, for instance, can become tougher to treat than the original irritation.
There’s no simple fix. The skin barrier on the face has fewer protective layers. Absorption happens faster here than other places on the body, so even a small amount can pack a hefty punch. For lighter problems, doctors reach for weaker options—often a hydrocortisone 1% cream—if they recommend a steroid at all. The same rules don’t apply to arms, legs, or the thick skin on palms. Hard lessons from direct experience stay with anyone who’s counseled a patient dealing with “topical steroid withdrawal”—where quitting the medication brings on severe redness and burning.
Most good outcomes start with a doctor’s advice. There’s no substitute for a dermatologist who’s seen thousands of rashes. They usually suggest using the tiniest amount, for the shortest time, and never near the eyes or on thin eyelid skin. After improvement, moisturizers and non-steroidal treatments often keep problems in check. Treatments like pimecrolimus or tacrolimus ointments step in as steroid alternatives, especially for chronic issues on sensitive skin.
Access to up-to-date research matters. Peer-reviewed studies, consensus guidelines from leading dermatology associations, and real-world patient stories all confirm the same message: strong steroids on the face call for restraint. Patients can spot red flags like burning, stinging, or changes in the texture of their skin. These signs mean it’s time to stop and check in with a healthcare provider immediately.
The short answer fits the evidence: mometasone furoate doesn't serve as the best choice for facial skin. For tough flare-ups—where other creams don’t deliver—a doctor may give specific, detailed instructions about how and how long to use it. But anyone looking for quick fixes or thinking one solution works for every rash needs to pause. Long-term skin health wins out over shortcuts every single time. Better to ask twice than deal with damage that lingers for years.
| Names | |
| Preferred IUPAC name | (11β,16α)-9,21-dichloro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl furan-2-carboxylate |
| Other names |
Elocon
Nasonex Asmanex Mometasone |
| Pronunciation | /moʊˈmiːtəˌsoʊn fjʊˈroʊ.eɪt/ |
| Preferred IUPAC name | (11β,16α)-9,21-Dichloro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-diene-17-yl furan-2-carboxylate |
| Other names |
Elocon
Asmanex Nasonex Mometasone Mometasone Furoate Monohydrate |
| Pronunciation | /moʊˈmiːtəˌsoʊn ˈfjʊəroʊeɪt/ |
| Identifiers | |
| CAS Number | 83919-23-7 |
| 3D model (JSmol) | `3D model (JSmol)` string for **Mometasone Furoate**: ``` COC(=O)C1=CC2(C(C1=O)C3CCC4(C(C3(CC2)O)CCC4(C(F)(F)F)Cl)C)OC(=O)C5=CC=CC=C5 ``` |
| Beilstein Reference | 1432076 |
| ChEBI | CHEBI:9406 |
| ChEMBL | CHEMBL1200690 |
| ChemSpider | 215420 |
| DrugBank | DB00764 |
| ECHA InfoCard | 03b58e8b-7a4e-4e80-8790-61b7e41abc77 |
| EC Number | EC 254-853-2 |
| Gmelin Reference | 113093 |
| KEGG | C16152 |
| MeSH | D017025 |
| PubChem CID | 441336 |
| RTECS number | WM8Q276T41 |
| UNII | 0NK921009T |
| UN number | UN2811 |
| CAS Number | 83919-23-7 |
| 3D model (JSmol) | `3D model (JSmol)` string for **Mometasone Furoate**: ``` CC1=CC(=O)C2C(C1C3CCC(C4=CC(=O)C=C(O4)C3(C2)C)F)OC(=O)C5=COC6=CC=CC=C65 ``` |
| Beilstein Reference | 1565183 |
| ChEBI | CHEBI:6827 |
| ChEMBL | CHEMBL1200302 |
| ChemSpider | 215395 |
| DrugBank | DB00764 |
| ECHA InfoCard | 100.064.316 |
| EC Number | 2.3.1.138 |
| Gmelin Reference | 85022 |
| KEGG | C16116 |
| MeSH | D008947 |
| PubChem CID | 441336 |
| RTECS number | WN8XM07G6M |
| UNII | 7XIK385FV1 |
| UN number | UN number not assigned |
| Properties | |
| Chemical formula | C27H30Cl2O6 |
| Molar mass | 458.49 g/mol |
| Appearance | White to almost white crystalline powder |
| Odor | Odorless |
| Density | 0.6 g/cm³ |
| Solubility in water | Practically insoluble in water |
| log P | 2.7 |
| Vapor pressure | <0.0000001 mmHg (25°C) |
| Acidity (pKa) | 12.70 |
| Basicity (pKb) | pKb = 6.7 |
| Magnetic susceptibility (χ) | -86.5e-6 cm³/mol |
| Refractive index (nD) | 1.584 |
| Viscosity | White to off-white cream. |
| Dipole moment | 2.82 D |
| Chemical formula | C27H30Cl2O6 |
| Molar mass | 418.477 g/mol |
| Appearance | white to off-white powder |
| Odor | Odorless |
| Density | 0.5 g/cm³ |
| Solubility in water | Insoluble in water |
| log P | 2.75 |
| Vapor pressure | < 0.0000001 mmHg at 25°C (estimated) |
| Acidity (pKa) | 12.52 |
| Basicity (pKb) | 8.18 |
| Magnetic susceptibility (χ) | -87.8×10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.585 |
| Dipole moment | 2.24 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 774.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of combustion (ΔcH⦵298) | -7113 kJ/mol |
| Std molar entropy (S⦵298) | 631.5 J·mol⁻¹·K⁻¹ |
| Pharmacology | |
| ATC code | R01AD09 |
| ATC code | R01AD09 |
| Hazards | |
| Main hazards | Possible main hazards of Mometasone Furoate: "May cause allergic skin reactions; may cause respiratory irritation; harmful if swallowed; avoid contact with eyes, skin, and clothing. |
| GHS labelling | GHS07 |
| Pictograms | nonRx, external-use, keep-out-of-reach-of-children |
| Hazard statements | Hazard statements: May cause allergy or asthma symptoms or breathing difficulties if inhaled. |
| Precautionary statements | Keep out of reach of children. For external use only. Avoid contact with eyes. If irritation develops, discontinue use and consult a physician. Use only as directed by your healthcare provider. |
| NFPA 704 (fire diamond) | Health: 2, Flammability: 1, Instability: 0, Special: |
| Flash point | > 220 °C |
| Autoignition temperature | > 525 °C |
| Lethal dose or concentration | LD50 (rat, oral) >2000 mg/kg |
| LD50 (median dose) | LD50 (oral, rat) > 2000 mg/kg |
| NIOSH | NA00022015888 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 2 spray each nostril once daily |
| Main hazards | May be harmful if swallowed, inhaled, or absorbed through skin; causes eye, skin, and respiratory tract irritation. |
| GHS labelling | GHS07 |
| Pictograms | GTIN, PC, SN, LOT, EXP |
| Hazard statements | H317: May cause an allergic skin reaction. H319: Causes serious eye irritation. H335: May cause respiratory irritation. |
| Precautionary statements | Do not use on broken or infected skin. Avoid contact with eyes. For external use only. Keep out of reach of children. If irritation develops, discontinue use and consult your doctor. |
| Flash point | > 218.6 °C |
| Autoignition temperature | 600 °C |
| Lethal dose or concentration | LD50 (mouse, oral): >2000 mg/kg |
| LD50 (median dose) | > 1050 mg/kg (Rat, oral) |
| NIOSH | 243732 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 0.1% |
| IDLH (Immediate danger) | Not listed |
| Related compounds | |
| Related compounds |
Beclometasone
Betamethasone Dexamethasone Fluticasone propionate Hydrocortisone Prednisolone |
| Related compounds |
Hydrocortisone
Prednisolone Prednisone Dexamethasone Beclometasone dipropionate Fluticasone propionate Betamethasone Triamcinolone Clobetasol propionate Budesonide |
Providing high-quality chemical products and logistics solutions for global trade partners.
